Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 17;6(1):114.
doi: 10.1038/s41746-023-00860-5.

Non-invasive chronic kidney disease risk stratification tool derived from retina-based deep learning and clinical factors

Affiliations

Non-invasive chronic kidney disease risk stratification tool derived from retina-based deep learning and clinical factors

Young Su Joo et al. NPJ Digit Med. .

Abstract

Despite the importance of preventing chronic kidney disease (CKD), predicting high-risk patients who require active intervention is challenging, especially in people with preserved kidney function. In this study, a predictive risk score for CKD (Reti-CKD score) was derived from a deep learning algorithm using retinal photographs. The performance of the Reti-CKD score was verified using two longitudinal cohorts of the UK Biobank and Korean Diabetic Cohort. Validation was done in people with preserved kidney function, excluding individuals with eGFR <90 mL/min/1.73 m2 or proteinuria at baseline. In the UK Biobank, 720/30,477 (2.4%) participants had CKD events during the 10.8-year follow-up period. In the Korean Diabetic Cohort, 206/5014 (4.1%) had CKD events during the 6.1-year follow-up period. When the validation cohorts were divided into quartiles of Reti-CKD score, the hazard ratios for CKD development were 3.68 (95% Confidence Interval [CI], 2.88-4.41) in the UK Biobank and 9.36 (5.26-16.67) in the Korean Diabetic Cohort in the highest quartile compared to the lowest. The Reti-CKD score, compared to eGFR based methods, showed a superior concordance index for predicting CKD incidence, with a delta of 0.020 (95% CI, 0.011-0.029) in the UK Biobank and 0.024 (95% CI, 0.002-0.046) in the Korean Diabetic Cohort. In people with preserved kidney function, the Reti-CKD score effectively stratifies future CKD risk with greater performance than conventional eGFR-based methods.

PubMed Disclaimer

Conflict of interest statement

T.H.R. was a former scientific adviser and owned stocks in Mediwhale. H.K. and G.L. are employees of Mediwhale, and G.L. owns stocks in Mediwhale. T.H.R. and G.L. hold the following patents that might have been affected by this study: 10–2018–0166720(KR), 10–2018–0166721(KR), 10–2018–0166722(KR), 62/694,901(US), 62/715,729(US), and 62/776,345 (US). All other authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Augmented saliency map according to deep-learning-derived retina-CKD probability.
Augmented saliency maps according to quartiles of deep-learning-derived retina-CKD probability in the a UK Biobank and b Korean Diabetic Cohort are shown. Saliency is represented in color-scale (scaled between 0 and 255). Highlighted areas along the arcade vessels were more prominent in images with higher deep-learning-derived retina-CKD probability.
Fig. 2
Fig. 2. Cumulative incidence of chronic kidney disease events according to Reti-CKD score quartiles in the UK Biobank and Korean Diabetic Cohort.
Cumulative chronic kidney disease (CKD) incidences are illustrated according to the Reti-CKD score quartile in the a UK Biobank and b Korean Diabetic Cohort. There was a clear association between CKD development and the Reti-CKD scores in both cohorts.
Fig. 3
Fig. 3. Study flow chart for derivation and validation of Reti-CKD score.
In phase 1, health-screening center data was used for the development of deep-learning algorithm. In phase 2, data from longitudinal cohorts were utilized for derivation and validation of Reti-CKD score. Reti-CKD score was derived based on a Cox model using the UK Biobank cohort. The performance of Reti-CKD score was subsequently validated using the UK Biobank and Korean Diabetic Cohort.

References

    1. Kim KM, Oh HJ, Choi HY, Lee H, Ryu DR. Impact of chronic kidney disease on mortality: a nationwide cohort study. Kidney Res Clin. Pr. 2019;38:382–390. doi: 10.23876/j.krcp.18.0128. - DOI - PMC - PubMed
    1. Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143:1157–1172. doi: 10.1161/CIRCULATIONAHA.120.050686. - DOI - PMC - PubMed
    1. Thompson S, et al. Cause of death in patients with reduced kidney function. J. Am. Soc. Nephrology JASN. 2015;26:2504–2511. doi: 10.1681/ASN.2014070714. - DOI - PMC - PubMed
    1. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733. doi: 10.1016/S0140-6736(20)30045-3. - DOI - PMC - PubMed
    1. Xie Y, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567–581. doi: 10.1016/j.kint.2018.04.011. - DOI - PubMed